Disproportionality analysis of BRAF and MEK inhibitors demonstrate risk of retinal detachment: an analysis of the FDA Adverse Event Reporting System.

HOME
>
論文・技術情報
>
Disproportionality analysis of BRAF and MEK inhibitors demonstrate risk of retinal detachment: an analysis of the FDA Adverse Event Reporting System.

アブストラクト
ジャーナル名	Canadian journal of ophthalmology. Journal canadien d'ophtalmologie
Pubmed追加日	2025/3/30
投稿者	Frey, Connor; Etminan, Mahyar
組織名	Department of Medicine, University of British Columbia, Vancouver, BC, Canada.;Department of Ophthalmology and Visual Sciences, University of British Columbia,;Vancouver, BC, Canada.. Electronic address: etminanm@mail.ubc.ca.
Pubmed リンク	https://www.ncbi.nlm.nih.gov/pubmed/40157389/